Recent advances in natriuretic peptides in congestive heart failure

Author： Boerrigter Guido Burnett Jr John C

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.13, Iss.6, 2004-06, pp. : 643-652

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Congestive Heart Failure: Pharmacological Agents and the Potential of BType Natriuretic Peptide

Current Medicinal Chemistry, Vol. 12, Iss. 12, 2005-06 ,pp. : 1439-1447

Bentham Science Publishers

Access to resources Recommend Favorite

Atrial natriuretic peptides in heart failure: pathophysiological significance, diagnostic and prognostic value

By Ghosh Nina Haddad Haissam

Canadian Journal of Physiology and Pharmacology, Vol. 89, Iss. 8, 2011-08 ,pp. : 587-591

NRC Research Press

Access to resources Recommend Favorite

Designer natriuretic peptides: a vision for the future of heart failure therapeutics

By Zakeri Rosita Burnett John C.

Canadian Journal of Physiology and Pharmacology, Vol. 89, Iss. 8, 2011-08 ,pp. : 593-601

NRC Research Press

Access to resources Recommend Favorite

Perindopril: In Congestive Heart Failure

By Simpson D. Noble S. Goa K.L.

Drugs, Vol. 62, Iss. 9, 2002-01 ,pp. : 1367-1377

Adis International

Access to resources Recommend Favorite

Bisoprolol for congestive heart failure

By Rosenberg Jens Gustafsson Finn

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 2, 2008-02 ,pp. : 293-300

Informa Healthcare

Access to resources Recommend Favorite